Protalix BioTherapeutics (PLX) Net Cash Flow (2010 - 2026)
Protalix BioTherapeutics' quarterly Net Cash Flow came in at $26.4 million in Q1 2026, up 9078.91% year-on-year from $287594.0 in Q1 2025, and up 2381.02% quarter-over-quarter from $1.1 million in Q4 2025.
Protalix BioTherapeutics has reported Net Cash Flow for 17 years, with the latest figure at $26.4 million in Q1 2026.
- For the quarter ending Q1 2026, Net Cash Flow rose 9078.91% year-over-year to $26.4 million; the trailing twelve-month figure through Mar 2026 stood at $21.7 million (up 71.29% YoY), and the FY2025 full-year result was -$5.0 million, down 29.08% from the prior year.
- Net Cash Flow for Q1 2026 stood at $26.4 million, up from $1.1 million in the prior quarter.
- The five-year high for Net Cash Flow was $26.4 million in Q1 2026, with the low at -$27.8 million in Q3 2023.
- Average Net Cash Flow over 5 years is $1.2 million, with a median of -$294000.0 recorded in 2025.
- Year-over-year, Net Cash Flow plunged 1483.83% in 2022 and soared 9078.91% in 2026.
- Tracing PLX's Net Cash Flow over 5 years: stood at $6.4 million in 2022, then tumbled by 49.31% to $3.3 million in 2023, then sank by 336.8% to -$7.7 million in 2024, then soared by 113.81% to $1.1 million in 2025, then jumped by 2381.02% to $26.4 million in 2026.
- The last three Net Cash Flow figures came in at $26.4 million (Q1 2026), $1.1 million (Q4 2025), and -$4.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 625.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 457.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -152.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 60.68 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | 26.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.40 Mn |
| Mar 31, 2026 | 26.40 Mn |
| Dec 31, 2025 | 1.06 Mn |
| Dec 31, 2025 | 1.06 Mn |
| Sep 30, 2025 | -4.24 Mn |
| Sep 30, 2025 | -4.24 Mn |
| Jun 30, 2025 | -1.57 Mn |
| Jun 30, 2025 | -1.57 Mn |
| Mar 31, 2025 | -294,000.00 |
| Mar 31, 2025 | -294,000.00 |
| Dec 31, 2024 | -7.70 Mn |
| Dec 31, 2024 | -7.70 Mn |
| Sep 30, 2024 | 24.43 Mn |
| Sep 30, 2024 | 24.43 Mn |
| Jun 30, 2024 | -3.79 Mn |
| Jun 30, 2024 | -3.79 Mn |
| Mar 31, 2024 | 3.58 Mn |
| Mar 31, 2024 | 3.58 Mn |
| Dec 31, 2023 | 3.25 Mn |
| Dec 31, 2023 | 3.25 Mn |
| Sep 30, 2023 | -27.77 Mn |
| Sep 30, 2023 | -27.77 Mn |
| Jun 30, 2023 | 15.18 Mn |
| Jun 30, 2023 | 15.18 Mn |
| Mar 31, 2023 | 15.97 Mn |
| Mar 31, 2023 | 15.97 Mn |
| Dec 31, 2022 | 6.42 Mn |
| Dec 31, 2022 | 6.42 Mn |
| Sep 30, 2022 | -1.77 Mn |
| Sep 30, 2022 | -1.77 Mn |
| Jun 30, 2022 | -7.00 Mn |
| Jun 30, 2022 | -7.00 Mn |
| Mar 31, 2022 | -22.09 Mn |
| Mar 31, 2022 | -22.09 Mn |
| Dec 31, 2021 | 28.30 Mn |
| Dec 31, 2021 | 28.30 Mn |
| Sep 30, 2021 | -23.24 Mn |
| Sep 30, 2021 | -23.24 Mn |
| Jun 30, 2021 | 14.06 Mn |
| Jun 30, 2021 | 14.06 Mn |
| Mar 31, 2021 | 1.60 Mn |
| Mar 31, 2021 | 1.60 Mn |
| Dec 31, 2020 | 4.69 Mn |
| Dec 31, 2020 | 4.69 Mn |
| Sep 30, 2020 | 8.67 Mn |
| Sep 30, 2020 | 8.67 Mn |
| Jun 30, 2020 | -9.37 Mn |
| Jun 30, 2020 | -9.37 Mn |
| Mar 31, 2020 | -3.59 Mn |
| Mar 31, 2020 | -3.59 Mn |
| Dec 31, 2019 | -3.66 Mn |
| Dec 31, 2019 | -3.66 Mn |
| Sep 30, 2019 | -3.67 Mn |
| Sep 30, 2019 | -3.67 Mn |
| Jun 30, 2019 | -5.27 Mn |
| Jun 30, 2019 | -5.27 Mn |
| Mar 31, 2019 | -7.65 Mn |
| Mar 31, 2019 | -7.65 Mn |
| Dec 31, 2018 | -3.92 Mn |
| Dec 31, 2018 | -3.92 Mn |
| Sep 30, 2018 | 13.41 Mn |
| Sep 30, 2018 | 13.41 Mn |
| Jun 30, 2018 | -8.08 Mn |
| Jun 30, 2018 | -8.08 Mn |
| Mar 31, 2018 | -9.74 Mn |
| Mar 31, 2018 | -9.74 Mn |
| Dec 31, 2017 | 17.67 Mn |
| Dec 31, 2017 | 17.67 Mn |
| Sep 30, 2017 | -1.23 Mn |
| Sep 30, 2017 | -1.23 Mn |
| Jun 30, 2017 | -13.42 Mn |
| Jun 30, 2017 | -13.42 Mn |
| Mar 31, 2017 | -15.56 Mn |
| Mar 31, 2017 | -15.56 Mn |
| Dec 31, 2016 | 12.10 Mn |
| Dec 31, 2016 | 12.10 Mn |
| Sep 30, 2016 | -3.50 Mn |
| Sep 30, 2016 | -3.50 Mn |
| Jun 30, 2016 | -12.42 Mn |
| Jun 30, 2016 | -12.42 Mn |
| Mar 31, 2016 | -9.56 Mn |
| Mar 31, 2016 | -9.56 Mn |
| Dec 31, 2015 | 40.66 Mn |
| Dec 31, 2015 | 40.66 Mn |
| Sep 30, 2015 | -10.08 Mn |
| Sep 30, 2015 | -10.08 Mn |
| Jun 30, 2015 | -4.60 Mn |
| Jun 30, 2015 | -4.60 Mn |
| Mar 31, 2015 | -6.27 Mn |
| Mar 31, 2015 | -6.27 Mn |
| Mar 31, 2014 | -8.68 Mn |
| Mar 31, 2014 | -8.68 Mn |
| Dec 31, 2013 | 1.58 Mn |
| Dec 31, 2013 | 1.58 Mn |
| Sep 30, 2013 | 58.30 Mn |
| Sep 30, 2013 | 58.30 Mn |
| Jun 30, 2013 | -8.83 Mn |
| Jun 30, 2013 | -8.83 Mn |
| Mar 31, 2013 | -10.28 Mn |
| Mar 31, 2013 | -10.28 Mn |
| Dec 31, 2012 | 1.58 Mn |
| Dec 31, 2012 | 1.58 Mn |
| Sep 30, 2012 | -8.99 Mn |
| Sep 30, 2012 | -8.99 Mn |
| Jun 30, 2012 | 13.88 Mn |
| Jun 30, 2012 | 13.88 Mn |
| Mar 31, 2012 | 18.44 Mn |
| Mar 31, 2012 | 18.44 Mn |
| Dec 31, 2011 | -7.35 Mn |
| Dec 31, 2011 | -7.35 Mn |
| Sep 30, 2011 | -9.17 Mn |
| Sep 30, 2011 | -9.17 Mn |
| Jun 30, 2011 | -6.29 Mn |
| Jun 30, 2011 | -6.29 Mn |
| Mar 31, 2011 | 14.30 Mn |
| Mar 31, 2011 | 14.30 Mn |
| Dec 31, 2010 | -8.76 Mn |
| Dec 31, 2010 | -8.76 Mn |
| Sep 30, 2010 | -10.93 Mn |
| Sep 30, 2010 | -10.93 Mn |